DDDRX
Price
$15.01
Change
+$0.06 (+0.40%)
Updated
Jun 12 closing price
Net Assets
827M
RLBGX
Price
$35.96
Change
+$0.13 (+0.36%)
Updated
Jun 12 closing price
Net Assets
245.62B
Interact to see
Advertisement

DDDRX vs RLBGX

Header iconDDDRX vs RLBGX Comparison
Open Charts DDDRX vs RLBGXBanner chart's image
Macquarie Wealth Builder R
Price$15.01
Change+$0.06 (+0.40%)
VolumeN/A
Net Assets827M
American Funds American Balanced R6
Price$35.96
Change+$0.13 (+0.36%)
VolumeN/A
Net Assets245.62B
DDDRX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DDDRX vs. RLBGX commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDRX is a StrongBuy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 246B vs. DDDRX (827M). RLBGX pays higher dividends than DDDRX: RLBGX (2.23) vs DDDRX (1.14). DDDRX was incepted earlier than RLBGX: DDDRX (22 years) vs RLBGX (16 years). DDDRX (1.34) is less costly to investors than RLBGX (0.25). DDDRX is a more actively managed with annual turnover of: 66.00 vs. RLBGX (44.00). DDDRX has a lower initial minimum investment than RLBGX: DDDRX (0) vs RLBGX (250). RLBGX annual gain was more profitable for investors over the last year : 7.21 vs. DDDRX (1.52). RLBGX return over 5 years is better than : 41.57 vs. DDDRX (28.02).
DDDRXRLBGXDDDRX / RLBGX
Total Expense Ratio1.310.25524%
Annual Report Gross Expense Ratio1.340.25536%
Fund Existence22 years16 years-
Gain YTD1.9735.50236%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets827M246B0%
Annual Yield % from dividends1.142.2351%
Returns for 1 year1.527.2121%
Returns for 3 years14.0034.2341%
Returns for 5 years28.0241.5767%
Returns for 10 years25.7062.9941%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHAT10.030.99
+10.95%
Phathom Pharmaceuticals
KAVL0.540.01
+1.41%
Kaival Brands Innovations Group
RBA107.33-0.22
-0.20%
RB Global
FUNC29.68-0.10
-0.34%
First United Corp
IBRX3.19-0.05
-1.54%
ImmunityBio